<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for City Centre & Ancoats PCN</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where City Centre & Ancoats PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0205052AD&amp;denomIds=2.5.5&amp;selectedTab=summary">Azilsartan medoxomil</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1357</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>12.11</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0205052ADAAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Azilsartan medoxomil 20mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0704050AC&amp;denomIds=7.4.5&amp;selectedTab=summary">Avanafil</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>27</td>
      <td>Drugs for erectile dysfunction</td>
      <td>751</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>9.01</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0704050ACAAAAAA&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Avanafil 50mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0704050ACAAABAB&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Avanafil 100mg tablets : 21</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0704050ACAAACAC&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Avanafil 200mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0401020B0&amp;denomIds=4.1.2&amp;selectedTab=summary">Buspirone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>256</td>
      <td>Anxiolytics</td>
      <td>788</td>
      <td>0.32</td>
      <td>0.03</td>
      <td>0.04</td>
      <td>7.09</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0401020B0AAAAAA&amp;denomIds=4.1.2&amp;selectedTab=summary" target="_blank">Buspirone 5mg tablets : 175</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0401020B0AAABAB&amp;denomIds=4.1.2&amp;selectedTab=summary" target="_blank">Buspirone 10mg tablets : 81</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1303000M0&amp;denomIds=13.3&amp;selectedTab=summary">Mepyramine maleate</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Topical local anaesthetics and antipruritics</td>
      <td>20</td>
      <td>0.10</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>6.57</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1303000M0AAAAAA&amp;denomIds=13.3&amp;selectedTab=summary" target="_blank">Mepyramine 2% cream : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0202010F0&amp;denomIds=2.2.1&amp;selectedTab=summary">Chlortalidone</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Thiazides and related diuretics</td>
      <td>913</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.94</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0202010F0AAAAAA&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Chlortalidone 50mg tablets : 12</a></div></td></tr></tbody></table>

        <h2>Prescribing where City Centre & Ancoats PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0&amp;denomIds=2.4&amp;selectedTab=summary">Bisoprolol fumarate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2238</td>
      <td>Beta-adrenoceptor blocking drugs</td>
      <td>4968</td>
      <td>0.45</td>
      <td>0.65</td>
      <td>0.06</td>
      <td>-3.64</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHhElEQVR4nO3de4xdRQHH8e8p8qgYCEaswZBOQMTUWG2CmKJWTQFTRxC0lURRW4UafOEDw4iWNCHqFGtBW0hFrfiASCBSK4fiHyi2xlQEjNFEolBG4wOaoBgfVGg7/jFntbvefXT33jtn9vw+yc3utrv3/HKzvz3nzpkzp4oxIiLdMCd3ABEZHhVepENUeJEOUeFFOkSFF+kQFV6kQ1R4kQ5R4UU6RIUX6RAVXqRDVPhSVJXmQMuMPSN3AJFhMa4+ATgTWAIsAg4D9gOPAvc0j/uCt7P2j2uli2cKUVWRGKvcMUpkXL0QuAx4JbAN2An8DHiKdJRrgNcAZwHzgC8C3wre/itH3kFS4Uuhwh8y4+p5wHpgIfA54Jbg7dOT/MypwKXAG4CrgS9P9jMlUeFLocJPmXF1BVwMXEEq+ubg7f5DfI7nA1cBrwAuC95u73vQDFT4UqjwU2Jc/Vzga8A+4JLg7Z9m+HwvBa4H/gh8eKbPl5sKXwoVflLG1cuA6wBPOhTvyy+3cfUc4D2kI4b1TOOIoS1U+FKo8OMyrp4LrCMNyr09ePvggLYzD/g88ALgvcHbXwxiO4OkwpdChe/JuHoR8HVgO7AmePvUELZ5FrAJ+AawLni7b9Db7BcVvhQq/CjG1UcAnwIuIO1t7xny9o8BNgAvBi4M3j48zO1PlwpfChX+v4yrlwLXAD8CPhG8/UfGLG8CrgUuDd5uy5VjqlT4UqjwGFefTBo0m0caMb83cyQAjKtPAm7jf28rDmSONC4VvhQdLnxz+PxJYDlwJXBz26a/NgOHW4AIrBzGWMJ0qPCl6GDhm9NhK4E1pAGyq4O3/8waagJN3g3AAuAtwdu/Z470f1T4UnSs8MbVZ5DmtD8EXB68/V3mSFPSzPJzwDnA2TnHF3pR4UvRkcIbVz+bNHHmdOCDwdudmSNNi3H1FcBSwAZv9+bOM0LXw0trGFefD9xP2qu/vNSyAwRvPwPcC9xqXH147jwjtIcvxSzewxtXP4t0amsB8I5SzmlPpjm83wQcDaxqw0Cj9vCSlXH1AuCnwB+AJbOl7ABNwT8EHAuszZsm0R6+FLNwD29cfQ5pYO6i4O3dufMMinH1M4G7ga8Eb7+aM4sKX4pZVnjj6o8DFwLnB293584zaMbVxwM7gI8Eb+/KlUOFL8UsKXzzvtYDpwHntfFc9aAYV58CfJ90jv7nOTLoPbwMjXH1YcBm4FTS6arOlB0gePtb4G3AbcbV83NkUOFlKJqr224CjgKWt+nc9DAFb3eRFtS8w7j6uGFvX4WXgWsGrbYCe0inp4q5fnwQgre3AzcAtxtXHznMbavwMlDG1ccCdwH3kS4hbe2VZMMUvN1Iek1ubObgD4UG7UpR4KBdMzK9HbgpeHtN7jxt0xT9m8C/gYuHsU6e9vAyEMbVJwI/BK5X2XtrjnbeBRxO2tMP/E5QKrz0nXH1YtJtm64M3m7JHKfVmvGMlcDTwM3G1UcNcnsqvPSVcfUq0rXrK4K338mdpwTNofxFwCPAD5q19QdC7+FL0fL38MbVzyFNkz0BuCB4+1jmSEUyrn436Xr6FYNYBluFL0VLC9/MnFtBmj13LbBJI/EzY1y9hLRc1nXAF/r5eqrwpWhZ4Zuiv550/7U/Ax8N3j6UN9Xs0UzK+RJwHPC+ZpbejKnwpWhJ4Y2rjyZND70EeJy0SuuuvKlmp+aP6luBTwPfBa4K3j4xk+dU4UuRsfDNii1nkm76sJT0y7c5ePurHHm6plkR92PAatJy2BuDt49M57lU+FIMsfDNnmU+8DpgGemebT8Bvg3cGbx9chg5ZLRmue6VwPuB3wO3AluDt3um+hwqfCn6XPim1HNJN3V4HnAS8CLSrZNOI81730maKbejqxe7tFEzQ+900mDpucHbU6b6s4dUeOPqd5LO3Y88qubjAWA/6Z7c+w76fOzHA6SF+gdtGNuoxnlM9H8Tfe8c4IjxHmHdG9eay+9Y33x95ETf2+Mx8v1j7QUeBR4DdgMPAr8GHmjz+u8yfcXt4auqWh1jvCF3jokoY38oY/+VONNude4AU6CM/aGMfVZi4UVkmlR4kQ4psfAlvF9Sxv5Qxj4rbtBORKavxD28iEzTwFfYmKmqqpYAZwB7YoxbqqpaBiwCfhlj/F7edMnYjM2/bQZujDG2Yp55j9dxLfAEcGeM8TdZwzV6ZHw1sBjYFWPckTdd0iPjeaR74s2NMa7Jm25yJezhF8cYPXB88/Uu4ETSpJG2GJWxqqo3k1Z8aZOxr+PjpJsctsnYjOcCT5ImbLXFqIwxxq3Aw8AtWVNNUQmFHzXIEGP8K/AB0lTQthg7ELIQeBVpDnpbjH0dNwKfBZbnidPT2NfxmCbn2TnCjKPXoNdLYoxFXEjU+kG75hBqMfAX4AHgZcDJpMO8bTmzjRibMcZ4f1VVrwX2tuyQ/uDX8YWkefM/jjFmu9fZwXpknA8Y4G8xxqw3YRzRI+NuYFWMcUPWYFPU+sKLSP+UcEgvIn2iwot0iAov0iEqvEiHqPAiHaLCi3SICi/SISq8SIeo8CIdosKLdIgKL9Ih/wGuj/rp3oSmawAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0AAAAAA&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Bisoprolol 5mg tablets : 567</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0AAABAB&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Bisoprolol 10mg tablets : 322</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0AAAJAJ&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Bisoprolol 2.5mg tablets : 733</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0AAAKAK&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Bisoprolol 3.75mg tablets : 130</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0AAALAL&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Bisoprolol 7.5mg tablets : 95</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0204000H0AAAMAM&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Bisoprolol 1.25mg tablets : 391</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1305010I0&amp;denomIds=13.5.1&amp;selectedTab=summary">Gamolenic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Preparations for eczema</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.89</td>
      <td>0.29</td>
      <td>-3.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0105020A0&amp;denomIds=1.5.2&amp;selectedTab=summary">Budesonide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Corticosteroids</td>
      <td>17</td>
      <td>0.18</td>
      <td>0.72</td>
      <td>0.18</td>
      <td>-2.95</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0105020A0AAACAC&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 3mg gastro-resistant capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=0105020A0AAAGAG&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 1mg orodispersible tablets sugar free : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=040201030&amp;denomIds=4.2.1&amp;selectedTab=summary">Risperidone</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>122</td>
      <td>Antipsychotic drugs</td>
      <td>2851</td>
      <td>0.04</td>
      <td>0.16</td>
      <td>0.04</td>
      <td>-2.59</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=040201030AAAAAA&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Risperidone 1mg tablets : 16</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=040201030AAABAB&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Risperidone 2mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=040201030AAACAC&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Risperidone 3mg tablets : 43</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=040201030AAADAD&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Risperidone 4mg tablets : 22</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=040201030AAAKAK&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Risperidone 500microgram tablets : 33</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1104010I0&amp;denomIds=11.4.1&amp;selectedTab=summary">Dexamethasone</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Corticosteroids</td>
      <td>55</td>
      <td>0.09</td>
      <td>0.50</td>
      <td>0.17</td>
      <td>-2.44</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1104010I0BBAAAD&amp;denomIds=11.4.1&amp;selectedTab=summary" target="_blank">Maxidex 0.1% eye drops : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1104010I0BCAAAE&amp;denomIds=11.4.1&amp;selectedTab=summary" target="_blank">Maxitrol eye drops : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U45992&amp;numIds=1104010I0BCABAF&amp;denomIds=11.4.1&amp;selectedTab=summary" target="_blank">Maxitrol eye ointment : 2</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>